IP Library Granted Patent US 7,838,009
Granted Patent B2
US 7,838,009 · App. 11/632,222 · Granted Nov 23, 2010

Use of botulinum toxin for the preparation of a medicament for the treatment of lithiasis of salivary gland, gall bladder, kidney, or pancreas

Assignees: Ipsen Pharma S.A.S.; Ipsen Biopharm Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,838,009
App. No.
11/632,222
Granted
Nov 23, 2010
Kind
B2
Abstract

The invention relates to the use of a pre-synaptic neuromuscular blocking substance for preparing a medicament intended to treat a gland, organ or duct obstructed by a naturally formed stone. This method can be applied notably for salivary gland, gall bladder, kidney or pancreas stones.

Claims (5)

1. A method of treating a subject with a kidney obstructed by a naturally formed kidney stone or a subject with pancreas obstructed by naturally formed pancreatic duct stone, said method comprising direct injection of an effective amount of a solution or suspension of botulinum toxin into the obstructed kidney or the obstructed pancreas.

2. The method of claim 1 , wherein the botulinum toxin is selected from the group consisting of botulinum toxin type A, botulinum toxin type B and botulinum toxin type F.

3. The method of claim 1 , wherein the botulinum toxin is botulinum toxin type A.

4. The method of claim 1 , wherein the subject has the naturally formed kidney stone.

5. The method of claim 1 , wherein the subject has the naturally formed pancreatic duct stone.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 27, 2010
From: IPSEN DEVELOPMENTS LIMITED
To: IPSEN BIOPHARM LIMITED
Reel/Frame 024452/0646 →
MERGER Recorded Mar 3, 2010
From: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.)
To: IPSEN PHARMA S.A.S.
Reel/Frame 024024/0806 →
CHANGE OF NAME Recorded Feb 18, 2010
From: IPSEN LIMITED
To: IPSEN DEVELOPMENTS LIMITED
Reel/Frame 023958/0182 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2008
From: D'ARBIGNY, PIERRE BERNARD; CHABRIER DE LASSAUNIERE, PIERE-ETIENNE; BARCOCK, ALAN
To: IPSEN LIMITED; SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.)
Reel/Frame 020354/0727 →
Priority Claims (1)
GB 0415490.2 · Jul 12, 2004 · national
Continuity (1)
Related Publication 20080292661A1 · Nov 27, 2008